Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MBNL1 | Q9NR56 | 1/20 | 0.36 |
| ▸ | AR | P10275 | 2/20 | 0.36 |
| ▸ | PDE10A | Q9Y233 | 1/20 | 0.36 |
| ▸ | ADORA2A | P29274 | 2/20 | 0.36 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.36 |
| ▸ | NR1I3 | Q14994 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | NPC1 | O15118 | 1/20 | 0.35 |
| ▸ | RAB9A | P51151 | 1/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
| ▸ | THRB | P10828 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
| ▸ | HPGD | P15428 | 1/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.34 |
| ▸ | TDO2 | P48775 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4438398 | 0.89 | BCHE (0.44) | NR1I3KMT2ANPC1RAB9ATDP1 | |
| SCHEMBL29531209 | 0.83 | CYP1A2 (0.43) | ARPDE10AADORA2AADORA1NR1I3 | |
| SCHEMBL4436178 | 0.83 | CYP1A2 (0.43) | ARPDE10AADORA2AADORA1NR1I3 | |
| SCHEMBL24796159 | 0.82 | LMNA (0.45) | PDE10AADORA2AKMT2ATDP1THRB | |
| SCHEMBL13658460 | 0.81 | RAB9A (0.50) | ARPDE10AKMT2ANPC1RAB9A | |
| SCHEMBL12486646 | 0.81 | BACE1 (0.49) | ADORA2AADORA1NR1I3KMT2ANPC1 | |
| SCHEMBL29769817 | 0.81 | AR (0.40) | ARADORA2AADORA1NR1I3KMT2A | |
| SCHEMBL13399632 | 0.81 | PDE10A (0.38) | ARPDE10ANPC1RAB9ASMN1; SMN2 | |
| SCHEMBL10318960 | 0.81 | AR (0.40) | ARADORA2AADORA1NR1I3KMT2A | |
| SCHEMBL30052647 | 0.81 | BACE1 (0.49) | ADORA2AADORA1NR1I3KMT2ANPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220402877-A1 | ELECTROLUMINESCENT DEVICE | Beijing Summer Sprout Technology Co., Ltd. (CN) | 2022-12-22 | — | — | US | disclosed |
| EP-3719099-A1 | PHOSPHORESCENT MATERIALS | Universal Display Corporation (US) | 2020-10-07 | — | — | EP | disclosed |
| US-20200176693-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2020-06-04 | — | — | US | disclosed |
| US-10600975-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2020-03-24 | — | — | US | disclosed |
| US-20190157576-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2019-05-23 | — | — | US | disclosed |
| US-10230060-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2019-03-12 | — | — | US | disclosed |
| EP-3327100-A2 | PHOSPHORESCENT MATERIALS | Universal Display Corporation (US) | 2018-05-30 | — | — | EP | disclosed |
| US-20180145267-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2018-05-24 | — | — | US | disclosed |
| US-20180145267-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2018-05-24 | — | — | US | disclosed |
| US-9911930-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2018-03-06 | — | — | US | disclosed |
| US-20130248832-A1 | Phosphorescent Materials | UNIVERSAL DISPLAY CORPORATION | 2013-09-26 | — | — | US | disclosed |
| US-20130248832-A1 | Phosphorescent Materials | UNIVERSAL DISPLAY CORPORATION | 2013-09-26 | — | — | US | disclosed |
| EP-2121871-B1 | PHOSPHORESCENT MATERIALS | UNIVERSAL DISPLAY CORP (US) | 2013-08-14 | — | — | EP | disclosed |
| US-8431243-B2 | Substituted 2-Phenyl quinoline complex with Iridium; high device efficiency, stability, and processibility | UNIVERSAL DISPLAY CORPORATION (US) | 2013-04-30 | — | — | US | disclosed |
| US-8431243-B2 | Substituted 2-Phenyl quinoline complex with Iridium; high device efficiency, stability, and processibility | UNIVERSAL DISPLAY CORPORATION (US) | 2013-04-30 | — | — | US | disclosed |
| EP-2489716-A2 | Phosphorescent materials | Universal Display Corporation (US) | 2012-08-22 | — | — | EP | disclosed |
| EP-2465912-A1 | Phosphorescent Materials | Universal Display Corporation (US) | 2012-06-20 | — | — | EP | disclosed |
| US-20080261076-A1 | Substituted 2-Phenyl quinoline complex with Iridium; high device efficiency, stability, and processibility | UNIVERSAL DISPLAY CORPORATION (US) | 2008-10-23 | — | — | US | disclosed |
| US-20080261076-A1 | Substituted 2-Phenyl quinoline complex with Iridium; high device efficiency, stability, and processibility | UNIVERSAL DISPLAY CORPORATION (US) | 2008-10-23 | — | — | US | disclosed |
| WO-2008109824-A2 | PHOSPHORESCENT MATERIALS | UNIVERSAL DISPLAY CORPORATION (US) | 2008-09-12 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080261076-A1 | Substituted 2-Phenyl quinoline complex with Iridium; high device efficiency, stability, and processibility | PCID2, ICMT, ORAI2 | MBNL1 4181/4885AR 3745/4885PDE10A 2790/4885 |
| US-20220402877-A1 | ELECTROLUMINESCENT DEVICE | MCOLN2, MCOLN1, LDHB | MBNL1 154/4885AR 3225/4885PDE10A 3440/4885 |
| US-20200176693-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | RUVBL2, TERT, OR10J3 | MBNL1 2972/4885AR 2404/4885PDE10A 4426/4885 |
| US-20180145267-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | PIEZO1, ORAI2, ICMT | MBNL1 744/4885AR 3103/4885PDE10A 2659/4885 |
| US-10230060-B2 | Organic electroluminescent materials and devices | RUVBL2, OR10J3, EML4 | MBNL1 1306/4885AR 2303/4885PDE10A 4564/4885 |
| US-10600975-B2 | Organic electroluminescent materials and devices | TERT, OR10J3, RUVBL2 | MBNL1 3201/4885AR 1521/4885PDE10A 4386/4885 |
| US-20190157576-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | PIEZO1, ORAI2, PORCN | MBNL1 811/4885AR 3107/4885PDE10A 2212/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.